Baumgart, D C <br/><br/>
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  May 2016 
 - 1090-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.13594  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Cohort Studies<br/>Colitis, Ulcerative--drug therapy<br/>Crohn Disease--drug therapy<br/>Female<br/>Germany<br/>Humans<br/>Leukocyte L1 Antigen Complex--analysis<br/>Male<br/>Prospective Studies<br/>Remission Induction<br/>Smoking--epidemiology<br/>Tumor Necrosis Factor-alpha--therapeutic use